A Review of the New 21st Century Coronavirus (novel coronavirus-2019)

Document Type : Review Article

Authors

1 MSc Student in Nursing -Student Research Committee - Mashhad University of Medical Sciences - Mashhad - Iran

2 BSc Student in Nursing -Student Research Committee - Mashhad University of Medical Sciences - Mashhad - Iran

3 BSc Student in Midwifery -Student Research Committee - Mashhad University of Medical Sciences - Mashhad - Iran

4 a, Medical Student, Department of Neuroscience, faculty of medicine, Mashhad University of Medical Sciences, Mashhad, Iran b.Neuroscience Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

5 MSc Student in nursing- Student Research Committee - Mashhad University of Medical Sciences - Mashhad - Iran

Abstract

Introduction: A new virus from coronavirus family which is common between humans and animals was discovered in several patients with acute respiratory infection in China in December. Thishas led to extensive studies in the field of virus recognition, pathogenesis, and finding new therapeutic modalities. In this regard, the present study is a review of findings related to Coronavirus 2019.
Materials and Methods: The current review study investigated the articles indexed in Persian and Latin databases of SID, Magira, CIVILICA, ISC, Pubmed, Embase, Scopus, Scholar, science direct, World Health Organization (WHO) reports, and protocols Clinically evaluated within 2000-2020 AD. The keywords which were searched included novel coronavirus, China, Coronavirus 2019, covid 19, Coronavirus and Acute Respiratory Syndrome. Finally, 47 studies were reviewed.
Results: The present study investigated the findings related to epidemiology, disease symptoms, disease diagnosis, treatment, transmission, and prevention of coronavirus 2019. The information in this review study was extracted from articles, recently published protocols, and valid statistics.
Conclusion: There exists sufficient evidence that this virus can be easily transmitted to others and causes deadly diseases. Accordingly, it is considered a serious global threat and all necessary precautions should be taken in the event of any suspected case. Experiences from Middle East Respiratory Syndrome (MERS)and Severe Acute Respiratory Syndrome (SARS) highlight the importance of rapidly finding the source for 2019-nCoV in order to stem the ongoing outbreak

Keywords

References

  1. Gao QY, Chen YX, Fang JY. 2019 novel coronavirus infection and gastrointestinal tract. J Dig Dis. 2020; In Press.
  2. Holshue M, DeBolt C, First LS, Lofy KH, Wiesman J, Bruce H, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med. 2020; 382(10):929-36.
  3. Phan LT, Nguyen TV, Luong QC, Nguyen TV, Nguyen HT, Le HQ, et al. Importation and human-to-human transmission of a novel coronavirus in Vietnam. N Engl J Med. 2020; 382(9):872-4.
  4. Zu ZY, Jiang MD, Xu PP, Chen W, Ni QQ, Lu GM, et al. Coronavirus disease 2019 (COVID-19): a perspective from China. Radiology. 2020; 21;200490.
  5. World Health Organization. Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). Geneva: World Health Organization; 2020.
  6. World Health Organization. WHO director-general's remarks at the media briefing on 2019-nCoV on 11 February 2020. Geneva: World Health Organization; 2020.
  7. Coronavirus update (Live): 111,758 Cases and 3,889 Deaths from COVID-19 Wuhan China Virus Outbreak. Worldomete. Available at: URL: https://www.worldometers.info/coronavirus; 2020.
  8. World Health Organization. Coronavirus disease 2019 (‎ COVID-19)‎: situation report, 49. Geneva: World Health Organization; 2020.
  9. Situation update worldwide, as of 10 March 2020. European Centre for Disease Prevention and Control. Available at: URL: https://www.ecdc.europa.eu/en/
    geographical-distribution-2019-ncov-cases    ; 2020.
  10. Fehr AR, Perlman S. Coronaviruses: an overview of their replication and pathogenesis. Coronaviruses. New York: Human Press; 2015. P. 1-23.
  11. Woo PC, Huang Y, Lau SK, Yuen KY. Coronavirus genomics and bioinformatics analysis. Viruses. 2010; 2(8):1804-20.
  12. Zhang SF, Tuo JL, Huang XB, Zhu X, Zhang DM, Zhou K, et al. Epidemiology characteristics of human coronaviruses in patients with respiratory infection symptoms and phylogenetic analysis of HCoV-OC43 during 2010-2015 in Guangzhou. PloS One. 2018; 13(1):e0191789.
  13. Banerjee A, Kulcsar K, Misra V, Frieman M, Mossman K. Bats and coronaviruses. Viruses. 2019; 11(1):E41.
  14. Lau SK, Lee P, Tsang AK, Yip CC, Tse H, Lee RA, et al. Molecular epidemiology of human coronavirus OC43 reveals evolution of different genotypes over time and recent emergence of a novel genotype
    due to natural recombination. J Virol. 2011; 85(21):11325-37.
  15. Woo PC, Lau SK, Li KS, Poon RW, Wong BH, Tsoi HW, et al. Molecular diversity of coronaviruses in bats. Virology. 2006; 351(1):180-7.
  16. Tang XC, Zhang JX, Zhang SY, Wang P, Fan XH, Li LF, et al. Prevalence and genetic diversity of coronaviruses in bats from China. J Virol. 2006; 80(15):7481-90.
  17. Fung TS, Liu DX. Human coronavirus: host-pathogen interaction. Ann Rev Microbiol. 2019; 73:529-57.
  18. Read JM, Bridgen JR, Cummings DA, Ho A, Jewell CP. Novel coronavirus 2019-nCoV: early estimation of epidemiological parameters and epidemic predictions. MedRxiv. 2020; 23:20018549.
  19. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020; 382(8):727-33.
  20. Centers for Disease Control and Prevention. SARS basics fact sheet. Washington, D.C: U.S. Department of Health & Human Services; 2016.
  21. World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV). Geneva: World Health Organization; 2018.
  22. Angeletti S, Benvenuto D, Bianchi M, Giovanetti M, Pascarella S, Ciccozzi M. COVID‐2019: the role of the nsp2 and nsp3 in its pathogenesis. J Med Virol. 2020; In Press.
  23. Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020; 395(10223):514-23.
  24. Wu P, Hao X, Lau EH, Wong JY, Leung KS, Wu JT, et al. Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020. Euro Surveill. 2020; 25(3):2000044.
  25. Peiris J, Lai S, Poon L, Guan Y, Yam L, Lim W, et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet. 2003; 361(9366):
    1319-25.
  26. Centers for Disease Control and Prevention. Interim clinical guidance for management of patients with confirmed 2019 novel coronavirus (2019-nCoV) infection. Washington, D.C: U.S. Department of Health & Human Services; 2020.
  27. Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, et al. Clinical characteristics of 140 patients infected by SARS‐CoV‐2 in Wuhan, China. Allergy. 2020; In Press.
  28. Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020; 25(3):2000045.
  29. Phan T. Novel coronavirus: from discovery to clinical diagnostics. Infect Genet Evol. 2020; 79:104211.
  30. Laboratory guidelines for detection and diagnosis
    of the novel coronavirus (2019-nCoV) infection. Washington, D.C: Pan American Health Organization: PAHO/WHO; 2020.
  31. Ng MY, Lee EY, Yang J, Yang F, Li X, Wang H, et al. Imaging profile of the COVID-19 infection: radiologic findings and literature review. Radiology. 2020; 2(1):e200034.
  32. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223):497-506.
  33. Zhang J, Zhou L, Yang Y, Peng W, Wang W, Chen X. Therapeutic and triage strategies for 2019 novel coronavirus disease in fever clinics. Lancet Respir Med. 2020; 8(3):e11-2.
  34. Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet. 2020; 395(10223):470-3.
  35. Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020; 30(3):269-71.
  36. Li G, De Clercq E. Therapeutic options for the 2019 novel coronavirus (nCoV-2019). Nat Rev Drug Discov. 2020; 19(3):149-50.
  37. Farnoosh G, Alishiri G, Zijoud SR, Dorostkar
    R, Farahani AJ. Understanding the 2019-novel coronavirus (2019-nCoV) and coronavirus disease (COVID-19) based on available evidence-a review study. J Mil Med. 2020; 22(1):1-11.
  38. Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med. 2020; 382(10):929-36.
  39. Lan L, Xu D, Ye G, Xia C, Wang S, Li Y, et al. Positive RT-PCR test results in patients recovered from COVID-19. JAMA. 2020; In Press.
  40. Ong SWX, Tan YK, Chia PY, Lee TH, Ng OT, Wong MSY, et al. Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient. JAMA. 2020; In Press.
  41. World Health Organization. Updated WHO advice for international traffic in relation to the outbreak of the novel coronavirus 2019-nCoV. Geneva: World Health Organization; 2020.
  42. World Health Organization. Advice on the use of masks the community, during home care and in health care settings in the context of the novel coronavirus (2019-nCoV) outbreak. Geneva: World Health Organization; 2020.
  43. World Health Organization. WHO director-general's opening remarks at the media briefing on COVID-19. Geneva: World Health Organization; 2020.
  44. Centers for Disease Control and Prevention. Preparing for COVID-19: long-term care facilities, nursing homes. Washington, D.C: U.S. Department of Health & Human Services; 2020.
  45. Young BE, Ong SWX, Kalimuddin S, Low JG, Tan SY, Loh J, et al. Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. JAMA. 2020; In Press.
  46. Hui DS, I Azhar E, Madani TA, Ntoumi F, Kock R, Dar O, et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health-The latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis. 2020; 91:264-6.
  47. Gralinski LE, Menachery VD. Return of the coronavirus: 2019-nCoV. Viruses. 2020; 12(2):E135.
Navid No
Volume 23, Supplement,
May 2020
Pages 20-34

Files

Share

How to cite

Statistics